The healthcare investment industry has been incurring various forms of change over the years. Investors such as Jacob Gottlieb have been investing huge amounts of capital into the healthcare sector. Jacob Gottlieb is now focused on funding healthcare companies through Altium Capital. The provision of funds comes in handy since these companies are able to expound on their research. Gottlieb mainly focuses on healthcare companies that have been coming up with advanced forms of treatment.
The healthcare companies that have collaborated with Altium Capital are such as; Oragenics, ORMP (Oramed Pharmaceuticals), and AMRN (Amarin Corporation). Oramed is focusing on coming up with alternative forms of treatment for people who have diabetes. Altium Capital invested in Oramed by also acquiring a 5.61% stake in the corporation. Oramed was able to achieve a breakthrough in their research by formulating some capsules that could be ingested orally for patients suffering from diabetes. By partnering with renowned scientists from various parts of the world, Oramed was able to succeed in their research.
Altium Capital has also invested in the AMRN (Amarin Corporation). The healthcare company is mainly focused on developing drugs that are meant to improve people’s cardiovascular health. The company has been able to come up with drugs such as Vascepa; this drug received FDA approval in 2012. Oragenics is also a beneficiary of the services offered by Altium Capital. The company has been focusing on formulating antibiotics that will be used to treat infectious diseases. The corporation has mainly focused on replacement therapy which entails the replacement of harmful bacteria with bacteria that is beneficial to the human body.
Jacob Gottlieb is also striving to make a positive impact in New York City by engaging in philanthropy. By joining hands with various non-profit organizations, he has been able to positively impact the lives of many individuals in New York City.